ijms-logo

Journal Browser

Journal Browser

Molecular Research in Gynecological Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 9591

Special Issue Editor

Special Issue Information

Dear Colleagues,

The Centers for Disease Control and Prevention recognizes five types of gynecologic cancers: cervical cancer, ovarian cancer, uterine cancer, vaginal cancer, and vulvar cancer. GLOBOCAN 2020 reports that these cancers represent the fifth leading cause of death due to cancer. Notably, a screening test that can detect gynecological cancers in their early stages exists only for cervical cancer. Consequently, screening tests for these cancers are a high priority. This is especially true for ovarian cancers, which are associated with a poor outcome. The American Cancer Society estimates that in 2023 in the United States, 19,710 women will be diagnosed with ovarian cancer and 13,270 women will die from ovarian cancer.

It is well known that benign gynecological diseases affect a huge number of women. It is estimated that adenomyosis and leiomyomas (also known as uterine fibroids) each affect approximately 20% of women of reproductive age and that endometriosis and polycystic ovary syndrome (PCOS) each affect approximately 10% of women of reproductive age. Other benign gynecological conditions also affect a significant percentage of women. However, benign gynecological diseases are oftentimes ignored. For example, in reference to endometriosis, the New York Times (April 27, 2021) states "Yet, it suffers from a branding problem: It falls into the abyss of “women’s diseases” (overlooked), diseases that do not kill you (unimportant), and menstrual problems (taboo)", and the Guardian (June 2, 2022) states "Doctors’ routine dismissal of women’s debilitating health problems as “benign” has contributed to gynaecology waiting lists soaring by 60% to more than half a million patients, a senior health leader has said." While benign gynecological diseases are generally not fatal, they have a significant adverse effect on the quality of life of millions of women.

The International Journal of Molecular Sciences introduces this Special Issue to create a collection of papers on specific topics and build a community of authors and readers to discuss the latest research and develop new ideas and research directions. This Special Issue is soliciting review articles, original research articles, and short communications regarding the molecular aspects of gynecological diseases. These include identifying markers that can be used in the screening and diagnosis of relevant gynecological diseases, investigating DNA mutations and cellular signalling pathways that lead to the development of the disease, investigating the involvement of the microbiota in various gynecological diseases, and identifying targets that can be used in the treatment of the disease including potential targets for CRISPR-mediated therapies.

Dr. David B. Alexander
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • malignant gynecological diseases
  • screening for gynecological cancers
  • benign gynecological conditions
  • screening for benign gynecological diseases
  • endometriosis
  • polycystic ovaries syndrome
  • ovarian cysts
  • uterine fibroids
  • leiomyomas
  • adenomyosis
  • pelvic inflammatory disease
  • vaginitis
  • vaginal dysbiosis
  • treatment targets for gynecological diseases

Related Special Issue

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

16 pages, 3310 KiB  
Article
Altered Glycolysis, Mitochondrial Biogenesis, Autophagy and Apoptosis in Peritoneal Endometriosis in Adolescents
by Elena P. Khashchenko, Mikhail Yu. Vysokikh, Maria V. Marey, Ksenia O. Sidorova, Ludmila A. Manukhova, Natalya N. Shkavro, Elena V. Uvarova, Vladimir D. Chuprynin, Timur Kh. Fatkhudinov, Leila V. Adamyan and Gennady T. Sukhikh
Int. J. Mol. Sci. 2024, 25(8), 4238; https://doi.org/10.3390/ijms25084238 - 11 Apr 2024
Viewed by 349
Abstract
Energy metabolism plays a pivotal role in the pathogenesis of endometriosis. For the initial stages of the disease in adolescents, this aspect remains unexplored. The objective of this paper was to analyze the association of cellular and endosomal profiles of markers of glycolysis, [...] Read more.
Energy metabolism plays a pivotal role in the pathogenesis of endometriosis. For the initial stages of the disease in adolescents, this aspect remains unexplored. The objective of this paper was to analyze the association of cellular and endosomal profiles of markers of glycolysis, mitochondrial biogenesis, apoptosis, autophagy and estrogen signaling in peritoneal endometriosis (PE) in adolescents. We included 60 girls aged 13–17 years in a case–control study: 45 with laparoscopically confirmed PE (main group) and 15 with paramesonephric cysts (comparison group). Samples of plasma and peritoneal fluid exosomes, endometrioid foci and non-affected peritoneum were tested for estrogen receptor (Erα/β), hexokinase (Hex2), pyruvate dehydrogenase kinase (PDK1), glucose transporter (Glut1), monocarboxylate transporters (MCT1 and MCT2), optic atrophy 1 (OPA1, mitochondrial fusion protein), dynamin-related protein 1 (DRP1, mitochondrial fission protein), Bax, Bcl2, Beclin1, Bnip3, P38 mitogen-activated protein kinase (MAPK), hypoxia-inducible factor 1 (Hif-1α), mitochondrial voltage-dependent anion channel (VDAC) and transforming growth factor (TGFβ) proteins as markers of estrogen signaling, glycolysis rates, mitochondrial biogenesis and damage, apoptosis and autophagy (Western-Blot and PCR). The analysis identified higher levels of molecules associated with proliferation (ERβ), glycolysis (MCT2, PDK1, Glut1, Hex2, TGFβ and Hif-1α), mitochondrial biogenesis (OPA1, DRP1) and autophagy (P38, Beclin1 and Bnip3) and decreased levels of apoptosis markers (Bcl2/Bax) in endometrioid foci compared to non-affected peritoneum and that in the comparison group (p < 0.05). Patients with PE had altered profiles of ERβ in plasma and peritoneal fluid exosomes and higher levels of Glut1, MCT2 and Bnip3 in plasma exosomes (p < 0.05). The results of the differential expression profiles indicate microenvironment modification, mitochondrial biogenesis, estrogen reception activation and glycolytic switch along with apoptosis suppression in peritoneal endometrioid foci already in adolescents. Full article
(This article belongs to the Special Issue Molecular Research in Gynecological Diseases)
Show Figures

Figure 1

13 pages, 1465 KiB  
Article
Proteomic Profiling Identifies Candidate Diagnostic Biomarkers of Hydrosalpinx in Endometrial Fluid: A Pilot Study
by Roberto Gonzalez-Martin, Pedro de Castro, Carmen Fernandez, Fernando Quintana, Alicia Quiñonero, Marcos Ferrando and Francisco Dominguez
Int. J. Mol. Sci. 2024, 25(2), 968; https://doi.org/10.3390/ijms25020968 - 12 Jan 2024
Viewed by 657
Abstract
Hydrosalpinx is a fluid occlusion and distension of the fallopian tubes, often resulting from pelvic inflammatory disease, which reduces the success of artificial reproductive technologies (ARTs) by 50%. Tubal factors account for approximately 25% of infertility cases, but their underlying molecular mechanisms and [...] Read more.
Hydrosalpinx is a fluid occlusion and distension of the fallopian tubes, often resulting from pelvic inflammatory disease, which reduces the success of artificial reproductive technologies (ARTs) by 50%. Tubal factors account for approximately 25% of infertility cases, but their underlying molecular mechanisms and functional impact on other reproductive tissues remain poorly understood. This proteomic profiling study applied sequential window acquisition of all theoretical fragment ion spectra mass spectrometry (SWATH-MS) to study hydrosalpinx cyst fluid and pre- and post-salpingectomy endometrial fluid. Among the 967 proteins identified, we found 19 and 17 candidate biomarkers for hydrosalpinx in pre- and post-salpingectomy endometrial fluid, respectively. Salpingectomy significantly affected 76 endometrial proteins, providing insights into the enhanced immune response and inflammation present prior to intervention, and enhanced coagulation cascades and wound healing processes occurring one month after intervention. These findings confirmed that salpingectomy reverses the hydrosalpinx-related functional impairments in the endometrium and set a foundation for further biomarker validation and the development of less-invasive diagnostic strategies for hydrosalpinx. Full article
(This article belongs to the Special Issue Molecular Research in Gynecological Diseases)
Show Figures

Figure 1

20 pages, 2675 KiB  
Article
MLLT11 Regulates Endometrial Stroma Cell Adhesion, Proliferation and Survival in Ectopic Lesions of Women with Advanced Endometriosis
by Katharina Proestling, Heinrich Husslein, Quanah James Hudson, Matthias Witzmann-Stern, Barbara Widmar, Zsuzsanna Bagó-Horváth, Lejla Sandrieser, Alexandra Perricos, René Wenzl and Iveta Yotova
Int. J. Mol. Sci. 2024, 25(1), 439; https://doi.org/10.3390/ijms25010439 - 28 Dec 2023
Viewed by 654
Abstract
MLLT11 is a gene implicated in cell differentiation and the development and progression of human cancers, but whose role in the pathogenesis of endometriosis is still unknown. Using quantitative RT-PCR and immunohistochemistry, we analyzed 37 women with and 33 women without endometriosis for [...] Read more.
MLLT11 is a gene implicated in cell differentiation and the development and progression of human cancers, but whose role in the pathogenesis of endometriosis is still unknown. Using quantitative RT-PCR and immunohistochemistry, we analyzed 37 women with and 33 women without endometriosis for differences in MLLT11 expression. We found that MLLT11 is reduced in the ectopic stroma cells of women with advanced stage endometriosis compared to women without endometriosis. MLLT11 knockdown in control stroma cells resulted in the downregulation of their proliferation accompanied by G1 cell arrest and an increase in the expression of p21 and p27. Furthermore, the knockdown of MLLT11 was associated with increased apoptosis resistance to camptothecin associated with changes in BCL2/BAX signaling. Finally, MLLT11 siRNA knockdown in the control primary stroma cells led to an increase in cell adhesion associated with the transcriptional activation of ACTA2 and TGFB2. We found that the cellular phenotype of MLLT11 knockdown cells resembled the phenotype of the primary endometriosis stroma cells of the lesion, where the levels of MLLT11 are significantly reduced compared to the eutopic stroma cells of women without the disease. Overall, our results indicate that MLLT11 may be a new clinically relevant player in the pathogenesis of endometriosis. Full article
(This article belongs to the Special Issue Molecular Research in Gynecological Diseases)
Show Figures

Figure 1

18 pages, 3235 KiB  
Article
Peritoneal Fluid Analysis of Advanced Ovarian Cancers after Hyperthermic Intraperitoneal Chemotherapy
by Wei-Chun Chen, Ting-Chang Chang, Hung-Hsueh Chou, Mei-Hsiu Cheng, Jun-Jie Hong, Yi-Shan Hsieh and Chao-Min Cheng
Int. J. Mol. Sci. 2023, 24(11), 9748; https://doi.org/10.3390/ijms24119748 - 05 Jun 2023
Viewed by 1721
Abstract
This study investigated miRNA and cytokine expression changes in peritoneal fluid samples of patients with advanced ovarian cancer (OVCA) after receiving hyperthermic intraperitoneal chemotherapy (HIPEC) during cytoreduction surgery (CRS). We collected samples prior to HIPEC, immediately after HIPEC, and 24/48/72 h after CRS [...] Read more.
This study investigated miRNA and cytokine expression changes in peritoneal fluid samples of patients with advanced ovarian cancer (OVCA) after receiving hyperthermic intraperitoneal chemotherapy (HIPEC) during cytoreduction surgery (CRS). We collected samples prior to HIPEC, immediately after HIPEC, and 24/48/72 h after CRS from a total of 6 patients. Cytokine levels were assessed using a multiplex cytokine array, and a miRNA PanelChip Analysis System was used for miRNA detection. Following HIPEC, miR-320a-3p, and miR-663-a were found to be immediately down-regulated but increased after 24 h. Further, significant upregulation post-HIPEC and sustained increases in expression were detected in six other miRNAs, including miR-1290, miR-1972, miR-1254, miR-483-5p, miR-574-3p, and miR-574-5p. We also found significantly increased expression of cytokines, including MCP-1, IL-6, IL-6sR, TIMP-1, RANTES, and G-CSF. The changing expression pattern throughout the study duration included a negative correlation in miR-320a-3p and miR-663-a to cytokines including RANTES, TIMP-1, and IL-6 but a positive correlation in miRNAs to cytokines including MCP-1, IL-6sR, and G-CSF. Our study found miRNAs and cytokines in the peritoneal fluid of OVCA patients demonstrated different expression characteristics following CRS and HIPEC. Both changes in expression demonstrated correlations, but the role of HIPEC remains unknown, prompting the need for research in the future. Full article
(This article belongs to the Special Issue Molecular Research in Gynecological Diseases)
Show Figures

Figure 1

20 pages, 3573 KiB  
Article
Possible Correlation between Urocortin 1 (Ucn1) and Immune Parameters in Patients with Endometriosis
by Monika Abramiuk, Karolina Frankowska, Krzysztof Kułak, Rafał Tarkowski, Paulina Mertowska, Sebastian Mertowski and Ewelina Grywalska
Int. J. Mol. Sci. 2023, 24(9), 7787; https://doi.org/10.3390/ijms24097787 - 24 Apr 2023
Viewed by 1218
Abstract
The etiology of endometriosis (EMS) has not been clearly elucidated yet, and that is probably the reason why its diagnostic process is frequently long-lasting and inefficient. Nowadays, the non-invasive diagnostic methods of EMS are still being sought. Our study aimed to assess the [...] Read more.
The etiology of endometriosis (EMS) has not been clearly elucidated yet, and that is probably the reason why its diagnostic process is frequently long-lasting and inefficient. Nowadays, the non-invasive diagnostic methods of EMS are still being sought. Our study aimed to assess the serum and peritoneal fluid levels of urocortin 1 (Ucn1) in patients with EMS and healthy women. Moreover, considering the immune background of the disease, the association between Ucn1 and several immune parameters was studied in both groups. We found that the serum Ucn1 level was significantly upregulated in women with EMS compared to healthy patients. Moreover, higher serum Ucn1 levels tended to correspond with more advanced stages of the disease (p = 0.031). Receiver operating characteristic (ROC) analysis revealed that based on serum Ucn1 levels, it is possible to distinguish deep infiltrating endometriosis (DIE) from among other EMS types. Together, these results indicate Ucn1 as a possible promising biomarker of EMS: however, not in isolation, but rather to enhance the effectiveness of other diagnostic methods. Full article
(This article belongs to the Special Issue Molecular Research in Gynecological Diseases)
Show Figures

Figure 1

Review

Jump to: Research

20 pages, 1416 KiB  
Review
Sindbis Virus Vaccine Platform: A Promising Oncolytic Virus-Mediated Approach for Ovarian Cancer Treatment
by Christine Pampeno, Silvana Opp, Alicia Hurtado and Daniel Meruelo
Int. J. Mol. Sci. 2024, 25(5), 2925; https://doi.org/10.3390/ijms25052925 - 02 Mar 2024
Viewed by 782
Abstract
This review article provides a comprehensive overview of a novel Sindbis virus vaccine platform as potential immunotherapy for ovarian cancer patients. Ovarian cancer is the most lethal of all gynecological malignancies. The majority of high-grade serous ovarian cancer (HGSOC) patients are diagnosed with [...] Read more.
This review article provides a comprehensive overview of a novel Sindbis virus vaccine platform as potential immunotherapy for ovarian cancer patients. Ovarian cancer is the most lethal of all gynecological malignancies. The majority of high-grade serous ovarian cancer (HGSOC) patients are diagnosed with advanced disease. Current treatment options are very aggressive and limited, resulting in tumor recurrences and 50–60% patient mortality within 5 years. The unique properties of armed oncolytic Sindbis virus vectors (SV) in vivo have garnered significant interest in recent years to potently target and treat ovarian cancer. We discuss the molecular biology of Sindbis virus, its mechanisms of action against ovarian cancer cells, preclinical in vivo studies, and future perspectives. The potential of Sindbis virus-based therapies for ovarian cancer treatment holds great promise and warrants further investigation. Investigations using other oncolytic viruses in preclinical studies and clinical trials are also presented. Full article
(This article belongs to the Special Issue Molecular Research in Gynecological Diseases)
Show Figures

Figure 1

39 pages, 1954 KiB  
Review
Copper in Gynecological Diseases
by Rocío A. Conforti, María B. Delsouc, Edith Zorychta, Carlos M. Telleria and Marilina Casais
Int. J. Mol. Sci. 2023, 24(24), 17578; https://doi.org/10.3390/ijms242417578 - 17 Dec 2023
Cited by 1 | Viewed by 1333
Abstract
Copper (Cu) is an essential micronutrient for the correct development of eukaryotic organisms. This metal plays a key role in many cellular and physiological activities, including enzymatic activity, oxygen transport, and cell signaling. Although the redox activity of Cu is crucial for enzymatic [...] Read more.
Copper (Cu) is an essential micronutrient for the correct development of eukaryotic organisms. This metal plays a key role in many cellular and physiological activities, including enzymatic activity, oxygen transport, and cell signaling. Although the redox activity of Cu is crucial for enzymatic reactions, this property also makes it potentially toxic when found at high levels. Due to this dual action of Cu, highly regulated mechanisms are necessary to prevent both the deficiency and the accumulation of this metal since its dyshomeostasis may favor the development of multiple diseases, such as Menkes’ and Wilson’s diseases, neurodegenerative diseases, diabetes mellitus, and cancer. As the relationship between Cu and cancer has been the most studied, we analyze how this metal can affect three fundamental processes for tumor progression: cell proliferation, angiogenesis, and metastasis. Gynecological diseases are characterized by high prevalence, morbidity, and mortality, depending on the case, and mainly include benign and malignant tumors. The cellular processes that promote their progression are affected by Cu, and the mechanisms that occur may be similar. We analyze the crosstalk between Cu deregulation and gynecological diseases, focusing on therapeutic strategies derived from this metal. Full article
(This article belongs to the Special Issue Molecular Research in Gynecological Diseases)
Show Figures

Figure 1

18 pages, 1866 KiB  
Review
Hyperandrogenism and Its Possible Effects on Endometrial Receptivity: A Review
by Allia Najmie Muhammad Yusuf, Mohd Fariz Amri, Azizah Ugusman, Adila A. Hamid, Norhazlina Abdul Wahab and Mohd Helmy Mokhtar
Int. J. Mol. Sci. 2023, 24(15), 12026; https://doi.org/10.3390/ijms241512026 - 27 Jul 2023
Cited by 4 | Viewed by 1997
Abstract
Endometrial receptivity is a state of the endometrium defined by its readiness for embryo implantation. When the receptivity of the endometrium is impaired due to hyperandrogenism or androgen excess, this condition can lead to pregnancy loss or infertility. Hyperandrogenism encompasses a wide range [...] Read more.
Endometrial receptivity is a state of the endometrium defined by its readiness for embryo implantation. When the receptivity of the endometrium is impaired due to hyperandrogenism or androgen excess, this condition can lead to pregnancy loss or infertility. Hyperandrogenism encompasses a wide range of clinical manifestations, including polycystic ovary syndrome (PCOS), idiopathic hirsutism, hirsutism and hyperandrogaenemia, non-classical congenital adrenal hyperplasia, hyperandrogenism, insulin resistance, acanthosis nigricans (HAIR-AN), ovarian or adrenal androgen-secreting neoplasms, Cushing’s syndrome, and hyperprolactinaemia. Recurrent miscarriages have been shown to be closely related to elevated testosterone levels, which alter the endometrial milieu so that it is less favourable for embryo implantation. There are mechanisms for endometrial receptivity that are affected by excess androgen. The HOXA gene, aVβ3 integrin, CDK signalling pathway, MECA-79, and MAGEA-11 were the genes and proteins affect endometrial receptivity in the presence of a hyperandrogenic state. In this review, we would like to explore the other manifestations of androgen excess focusing on causes other than PCOS and learn possible mechanisms of endometrial receptivity behind androgen excess leading to pregnancy loss or infertility. Full article
(This article belongs to the Special Issue Molecular Research in Gynecological Diseases)
Show Figures

Figure 1

Back to TopTop